Frontiers in Cellular and Infection Microbiology

Scope & Guideline

Pioneering research for a healthier tomorrow.

Introduction

Delve into the academic richness of Frontiers in Cellular and Infection Microbiology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2235-2988
PublisherFRONTIERS MEDIA SA
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2011 to 2024
AbbreviationFRONT CELL INFECT MI / Front. Cell. Infect. Microbiol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND

Aims and Scopes

The journal 'Frontiers in Cellular and Infection Microbiology' focuses on advancing knowledge in the areas of infectious diseases and microbial interactions with host cells. It encompasses a wide array of research themes, methodologies, and perspectives that contribute to understanding cellular microbiology, pathogen biology, and the implications for treatment and prevention of infections.
  1. Infection Biology and Pathogenesis:
    Research on the mechanisms of infection by various pathogens, including bacteria, viruses, fungi, and parasites. Studies often focus on understanding how these microorganisms exploit host cellular processes to establish infections.
  2. Host-Microbe Interactions:
    Investigations into how the host immune system interacts with pathogens and commensal organisms, including the role of the gut microbiome in health and disease.
  3. Antimicrobial Resistance and Novel Therapeutics:
    Research aimed at understanding the mechanisms of antimicrobial resistance and the development of new therapeutic strategies, including the use of phage therapy, probiotics, and novel drug compounds.
  4. Microbial Genomics and Metagenomics:
    Utilization of advanced genomic techniques to analyze microbial communities, pathogen genomes, and their implications for disease diagnosis and treatment.
  5. Clinical Microbiology and Diagnostics:
    Application of innovative diagnostic tools, including metagenomic next-generation sequencing, to improve pathogen detection and patient outcomes in infectious diseases.
  6. Translational Research:
    Focus on bridging laboratory research with clinical applications, including the development of vaccines and therapeutic interventions based on microbiome research.
The journal has seen significant growth in specific research areas that reflect current global health challenges and scientific advancements. These emerging themes are critical for understanding contemporary issues in microbiology and infectious diseases.
  1. Gut Microbiota and Health:
    Research focusing on the gut microbiome and its implications for various diseases, including metabolic disorders, autoimmune diseases, and infections, has surged. This reflects a growing recognition of the microbiome's role in overall health.
  2. COVID-19 Research:
    There has been an explosive increase in studies related to SARS-CoV-2, encompassing various aspects such as pathogenesis, immune response, diagnostics, and long-term effects, as the pandemic continues to influence global health.
  3. Antimicrobial Resistance Mechanisms:
    A growing body of research is dedicated to elucidating the mechanisms behind antimicrobial resistance, including the genetic and phenotypic characteristics of resistant strains, which is crucial for developing new treatment strategies.
  4. Phage Therapy and Novel Antimicrobials:
    Interest in bacteriophage therapy and other novel antimicrobial agents has increased as potential alternatives to traditional antibiotics, particularly in the context of rising antimicrobial resistance.
  5. Infection Control and Prevention Strategies:
    Studies focusing on innovative infection control measures, including the use of probiotics, dietary interventions, and environmental factors affecting microbial infection rates, are trending.

Declining or Waning

While the journal covers a broad range of topics, some areas have seen a decline in prominence over recent years. This may reflect shifting research priorities or advancements in specific methodologies that have changed the focus of the research community.
  1. Traditional Culture-Based Microbiology:
    There has been a noticeable decline in publications focusing solely on traditional culture-based methods for microbial identification and susceptibility testing, as newer techniques such as metagenomics gain prominence.
  2. Basic Virology Studies:
    Research papers dedicated to basic virology without a clear link to clinical implications or translational applications have become less frequent, as the focus shifts towards understanding viral pathogenesis and therapeutic strategies.
  3. Historical Epidemiological Studies:
    There appears to be a reduction in the publication of historical epidemiological studies that do not incorporate modern analytical techniques or tools, as more researchers seek to apply contemporary methods to solve current health issues.
  4. Studies on Non-Pathogenic Microbes:
    The exploration of non-pathogenic microbes and their roles in human health has decreased, with more emphasis placed on pathogenic microbes and their interactions with the immune system.

Similar Journals

Indian Journal of Medical Microbiology

Connecting Global Scholars in Microbiology and Infectious Diseases
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Surgical Infections

Transforming research into practice for surgical infection control.
Publisher: MARY ANN LIEBERT, INCISSN: 1096-2964Frequency: 10 issues/year

Surgical Infections, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to advancing the understanding and management of infections associated with surgical procedures. With an ISSN of 1096-2964 and an E-ISSN of 1557-8674, this journal has emerged as a vital resource within the fields of Infectious Diseases, Surgery, and Microbiology. Over the years, it has established a notable presence, achieving a 2023 Q2 ranking in Infectious Diseases and Surgery, as well as a Q3 ranking in Microbiology. The journal holds an impressive position at 74th percentile in Surgery according to Scopus, making it a reliable platform for disseminating current research and clinical practices. Surgical Infections aims to provide an interdisciplinary forum for both seasoned professionals and academics, encouraging the exploration of novel therapeutic approaches, prevention strategies, and case studies that address the complexities of surgical-related infections. As the field continues to evolve, this journal remains committed to fostering innovative research that enhances clinical outcomes and patient safety.

Gut Pathogens

Unlocking Insights for Better Gut Health
Publisher: BMCISSN: 1757-4749Frequency: 1 issue/year

Gut Pathogens, published by BMC in the United Kingdom, is a premier open-access journal focusing on the intersection of gut health and infectious diseases. With its impact firmly established since its inception in 2009, the journal has earned impressive rankings, including Q1 in renowned categories such as Gastroenterology, Infectious Diseases, Microbiology, and Parasitology, while maintaining a strong presence in Virology. The journal serves as a vital resource for researchers, professionals, and students interested in the intricate relationships between gut microbiota and pathogenic organisms, offering insights that drive advancements in treatment and prevention strategies. By providing unrestricted access to high-quality research, Gut Pathogens fosters a collaborative environment, encouraging the dissemination of knowledge and innovation within the field. The journal publishes original research, reviews, and case studies, all designed to address contemporary challenges in gut health, ultimately aiming to improve patient outcomes and public health worldwide.

Journal of Pathogens

Pioneering Discoveries in Microbial Science
Publisher: HINDAWI LTDISSN: 2090-3057Frequency:

Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

Brazilian Journal of Infectious Diseases

Connecting scholars and practitioners to combat infectious diseases.
Publisher: ELSEVIER BRAZILISSN: 1413-8670Frequency: 6 issues/year

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

Current Research in Microbial Sciences

Advancing the Frontiers of Microbial Knowledge
Publisher: ELSEVIERISSN: 2666-5174Frequency: 1 issue/year

Current Research in Microbial Sciences is a distinguished peer-reviewed journal published by Elsevier, focusing on the dynamic and rapidly advancing fields of microbiology and infectious diseases. With an ISSN of 2666-5174, this journal has established itself as an essential resource for researchers, professionals, and students alike, offering the latest findings and insights from 2020 to 2024. The journal holds a significant position in the academic landscape, achieving a Q2 ranking across multiple categories, including Immunology and Microbiology, Infectious Diseases, and Medical Microbiology, demonstrating its impact in these critical areas of study. With impressive Scopus rankings—such as being placed in the 94th percentile for Immunology and Microbiology—current research is well-supported by a thriving scientific community. Although the journal is not open access, it serves as a vital platform for disseminating high-quality research and fostering collaboration within the microbial sciences. Engaging with this journal enables professionals and researchers to stay abreast of innovations and contribute to the collective body of knowledge that shapes our understanding of microbial interactions and infectious diseases.

CELLULAR MICROBIOLOGY

Advancing the Frontiers of Cellular Interactions
Publisher: WILEY-HINDAWIISSN: 1462-5814Frequency: 1 issue/year

CELLULAR MICROBIOLOGY, published by Wiley-Hindawi, is a prominent journal in the fields of Immunology, Microbiology, and Virology. With its ISSN 1462-5814 and E-ISSN 1462-5822, this journal serves as a vital platform for researchers to disseminate their findings and contribute to the growing body of knowledge surrounding cellular interactions and microbial processes. Operating from the United Kingdom, CELLULAR MICROBIOLOGY has distinguished itself by ranking in the top quartile of Microbiology (Q1) and maintaining a solid Q2 status in both Immunology and Virology as of 2023. The journal has also demonstrated excellent performance in Scopus rankings, boasting significant percentiles in its respective categories. Although primarily subscription-based, the journal aims to continuously advance the understanding of cellular microbiology through rigorous peer-reviewed research spanning from 1999 to 2024. Researchers, professionals, and students alike will find this journal an invaluable resource for the latest scientific breakthroughs and theoretical advancements in the microbiological and immunological realms.

Infectious Diseases and Clinical Microbiology

Fostering collaboration in the fight against infectious agents.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

CLINICAL MICROBIOLOGY AND INFECTION

Advancing the Science of Infection
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

JOURNAL OF INFECTION

Driving Progress in the Fight Against Infectious Diseases
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.